Evolva, founded in 2004 and headquartered in Switzerland, is positioned at the intersection of Biotechnology, Food and Beverage, Health Care, and Health and Wellness. The company utilizes advanced technology platforms, such as fermentation, to address sourcing challenges in nature. This innovative approach allows Evolva to produce high-quality ingredients that are consistently available and based on nature, catering to health, wellbeing, and sensory experiences.
With a diverse team of approximately 55 employees representing 15 nationalities, Evolva fosters an interdisciplinary and inclusive work environment. The company's commitment to research and commercialization ensures the availability of affordable and ready-to-formulate products. Notably, their latest financial backing was a $540.00K grant investment from the Centers for Disease Control and Prevention in October 2022, underlining a strong endorsement from a reputable entity. Investors should consider Evolva’s potential for continued growth and impact within its sectors.